Advances in screening and new therapies have transformed the outlook for people with lung cancer, one Colorado doctor says, ...

Steve Merlin works with fellow pancreatic cancer patients, telling his remarkable story of surviving 13 years since his ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...

For more than two decades, Dr. Ross Camidge has been a leading voice in lung cancer research, helping thousands of patients around the world defy the odds. Now, the internationally recognized ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Three hours inland from Chennai, India, traffic crawls on a half-finished road past rice fields and cow crossings until it reaches a newer complex of neat white buildings. Among them is the cancer ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

Artificial intelligence is making its mark on the future of cancer care. One of the newest applications for the technology is pinpointing hard-to-detect breast cancer. Researchers at Ohio State ...